Two targeted pills showed promise against eye melanoma that has spread
In a phase 2 study published Oct. 28, 2026, in the Journal of Clinical Oncology, 44 previously untreated people with metastatic uveal melanoma took darovasertib plus crizotinib. Tumors shrank in 34.1%, and…